Organization (Nonprofit)
Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov lists Seattle Institute for Biomedical and Clinical Research as lead sponsor of 49 trials. It has 18 active development programs and 14 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Seattle Institute for Biomedical and Clinical Research: 49 lead-sponsored trials and 1 legal-entity registration.
Disease areas (52)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Stress Disorders, Post-Traumatic | 13 |
| Substance-Related Disorders | 10 |
| Alcoholism | 7 |
| Alzheimer Disease | 5 |
| Dementia | 5 |
Showing 5 of 52 disease areas.
Trials by start year as sponsor or collaborator (22)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2024 | 3 |
| 2023 | 2 |
| 2021 | 4 |
| 2019 | 2 |
| 2018 | 3 |
| 2017 | 1 |
| 2016 | 2 |
| 2015 | 4 |
| 2012 | 2 |
Showing 10 of 22 years.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (18)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| Testosterone 1.62% gel | Fatigue | Phase 2 | 1 |
| Testosterone 1.62% gel | Hypogonadism | Phase 2 | 1 |
| Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED] | Eunuchism | Phase 2 | 1 |
| Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED] | Hypogonadism | Phase 2 | 1 |
| Testosterone 1.62% gel | Eunuchism | Phase 2 | 1 |
Showing 5 of 18 active programs.
Approved assets (14)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Prazosin | 8 |
| Quetiapine | 2 |
| PRAVASTATIN SODIUM | 1 |
| SIMVASTATIN | 1 |
| Galantamine | 1 |
Showing 5 of 14 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 35% hit target (n=17) | 32% on time (n=19) |
Journals published in (68)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Diabetes | 10 |
| Diabetes care | 5 |
| Diabetologia | 5 |
| Neurology | 5 |
| JAMA | 4 |
Showing 5 of 68 journals.
Organization relationships (6)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Government of the United States of America | Co sponsors trial with | 5 |
| University of California System | Co sponsors trial with | 1 |
| Eisai (Japan) | Co sponsors trial with | 1 |
| PriCara, Unit of Ortho-McNeil, Inc. | Co sponsors trial with | 1 |
| VA Tennessee Valley Health Care System | Co sponsors trial with | 1 |
Showing 5 of 6 relationships.
Latest dated events (57)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-12-19 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-07-29 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-03-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 57 events.
Biomarker capability evidence (110)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| APP | Trial sponsor | Named in trial inclusion criteria |
| ATM | Trial sponsor | Named in trial inclusion criteria |
| BRCA1 | Trial sponsor | Named in trial inclusion criteria |
| BRCA2 | Trial sponsor | Named in trial inclusion criteria |
| HRH2 | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 110 evidence rows.
Biomarkers this organization publishes on (3)
Shown in this order: most publications first.
On Scientist.com
Seattle Institute for Biomedical and Clinical Research is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Seattle Institute for Biomedical and Clinical Research on Scientist.com
For prices, more details, or to contact Seattle Institute for Biomedical and Clinical Research, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.